ES8802026A1 - Procedimiento para preparar dihidropiridinas. - Google Patents

Procedimiento para preparar dihidropiridinas.

Info

Publication number
ES8802026A1
ES8802026A1 ES551843A ES551843A ES8802026A1 ES 8802026 A1 ES8802026 A1 ES 8802026A1 ES 551843 A ES551843 A ES 551843A ES 551843 A ES551843 A ES 551843A ES 8802026 A1 ES8802026 A1 ES 8802026A1
Authority
ES
Spain
Prior art keywords
ring
bears
alkyl
substituents
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551843A
Other languages
English (en)
Other versions
ES551843A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES8802026A1 publication Critical patent/ES8802026A1/es
Publication of ES551843A0 publication Critical patent/ES551843A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DIHIDROPIRIDINAS, DE FORMULA GENERAL (I), Y SUS SALES DE ADICION DE ACIDOS FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN HACER REACCIONAR UNA AMIONA DE FORMULA GENERAL (II), EN LA QUE R1 ES ALQUILO O ALCOXIALQUILO; R2 Y R3, QUE PUEDEN SER IGUALES O DIFERENTES, REPRESENTAN ALQUILO DE HASTA 6 ATOMOS DE CARBONO; AR ES FENILO O NAFTILO; X ES OXIGENO O NH; E Y ES ALQUILENO DE CADENA RECTA O RAMIFICADA DE 2 A 12 ATOMOS DE CARBONO, CON UN EPOXIDO DE FORMULA GENERAL (II). DE APLICACION EN MEDICINA POR SUS PROPIEDADES ANTIHIPERTENSIVAS.
ES551843A 1985-02-11 1986-02-11 Procedimiento para preparar dihidropiridinas. Expired ES8802026A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503424A GB8503424D0 (en) 1985-02-11 1985-02-11 Heterocyclic derivatives

Publications (2)

Publication Number Publication Date
ES8802026A1 true ES8802026A1 (es) 1988-03-16
ES551843A0 ES551843A0 (es) 1988-03-16

Family

ID=10574269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551843A Expired ES8802026A1 (es) 1985-02-11 1986-02-11 Procedimiento para preparar dihidropiridinas.

Country Status (14)

Country Link
EP (1) EP0194750A1 (es)
JP (1) JPS61246162A (es)
AU (2) AU5397486A (es)
DK (1) DK66086A (es)
ES (1) ES8802026A1 (es)
FI (1) FI860622A (es)
GB (1) GB8503424D0 (es)
GR (1) GR860382B (es)
HU (1) HUT40416A (es)
IL (1) IL77849A0 (es)
NO (1) NO860471L (es)
PT (1) PT82021B (es)
WO (1) WO1986004581A1 (es)
ZA (1) ZA86997B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
EP0254682A1 (de) * 1986-07-22 1988-01-27 Ciba-Geigy Ag Neue Phenoxyaliphatylphenylenoxyalkylester und -amide
EP0276552A1 (en) * 1986-12-08 1988-08-03 Yamanouchi Pharmaceutical Co. Ltd. 1,4-dihydropyridine derivatives and their production
IT1229118B (it) * 1988-07-29 1991-07-22 Simes Composti attivi sul sistema cardiovascolare che presentano sia la struttura dei beta-bloccanti sia una porzione calcio-antagonista
EP0352863A3 (en) * 1988-07-29 1990-08-22 ZAMBON GROUP S.p.A. 1,4-dihydropyridine dicarboxylic acid derivatives
US5468746A (en) * 1988-07-29 1995-11-21 Zambon Group S.P.A. Compounds active on the cardiovascular system
KR940005016B1 (ko) * 1990-11-30 1994-06-09 후지레비오 가부시끼가이샤 1,4-디히드로피리딘 유도체 및 그의 제조방법
DE4131346A1 (de) * 1991-09-20 1993-03-25 Bayer Ag Indolsulfonamid substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
AU4586093A (en) * 1992-07-28 1994-02-14 Daicel Chemical Industries Ltd. Antihypertensive 1,4-dihydropyridine derivatives and process for their preparation
NL1012886C1 (nl) 1999-08-23 2001-02-26 Rephartox 1,4-Dihydropyridine-5-carbonzuuresterderivaten en werkwijze voor de bereiding ervan.
US20080255134A1 (en) * 2004-11-30 2008-10-16 Artesian Therapeutics, Inc. Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
CN101215258A (zh) * 2008-01-21 2008-07-09 中国药科大学 二氢吡啶类钙拮抗剂化合物及其制备方法与医药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
ES551843A0 (es) 1988-03-16
NO860471L (no) 1986-08-12
AU5339386A (en) 1986-08-14
ZA86997B (en) 1986-12-30
PT82021A (en) 1986-03-01
WO1986004581A1 (en) 1986-08-14
EP0194750A1 (en) 1986-09-17
FI860622A0 (fi) 1986-02-11
HUT40416A (en) 1986-12-28
IL77849A0 (en) 1986-08-31
AU5397486A (en) 1986-08-26
DK66086D0 (da) 1986-02-11
FI860622A (fi) 1986-08-12
DK66086A (da) 1986-08-12
PT82021B (en) 1987-12-16
GR860382B (en) 1986-05-29
GB8503424D0 (en) 1985-03-13
JPS61246162A (ja) 1986-11-01

Similar Documents

Publication Publication Date Title
ES8802026A1 (es) Procedimiento para preparar dihidropiridinas.
DE3366917D1 (en) New thrombin inhibiting compounds
SU1279528A1 (ru) "cпocoб пoлучehия 1,4-дигидpoпиpидиhob или иx гидpoxлopидob"
ES534505A0 (es) Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina
FR2592879B1 (fr) Nouveaux derives de la decahydroquinoleine, leur procede de preparation, les intermediaires de preparation, leur application a titre de medicaments et les compositions les renfermant
ES8307218A1 (es) Proceso de fabricacion de los nuevos derivados de la amidinopiperadina.
ES8802030A1 (es) Procedimiento para preparar dihidropiridinas.
ES8802139A1 (es) Procedimiento para preparar dihidropiridinas.
ES8802028A1 (es) Procedimiento para preparar dihidropiridinas.
ES8701725A1 (es) Procedimiento para la preparacion de 1,4-dihidropiridina-hidroximina.
DK160486C (da) N-(4-amino-2,2-diphenyl-butyl)- eller n-(3-amino-2,2-diphenyl-propyl) urinstofforbindelser, fremgangsmaade til fremstilling af disse, samt en farmaceutisk komposition
ES527739A0 (es) Un procedimiento para preparar derivados de pirimidina
ES8802027A1 (es) Procedimiento para preparar dihidropiridinas.
ES8802029A1 (es) Procedimiento para preparar dihidropiridinas.
ES8201541A1 (es) Un procedimiento para la preparacion de nuevas guanilamidi- nas
IL80402A0 (en) Dihydropyridines and pharmaceutical compositions containing them
FR2633292B1 (fr) Nouveaux derives de la 20,21-dinoreburnamenine substitues en 15 par un groupement amine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les reenfermant
MY101878A (en) 1,3,4-thiadiazole